Laboratório de Ciências Químicas, Universidade Estadual do Norte Fluminense Darcy Ribeiro, Campos dos Goytacazes, 28013-602 RJ, Brazil.
J Inorg Biochem. 2013 Nov;128:38-47. doi: 10.1016/j.jinorgbio.2013.07.019. Epub 2013 Jul 19.
The nuclease activity and the cytotoxicity toward human leukemia cancer cells of iron complexes, [Fe(HPClNOL)Cl2]NO3 (1), [Cl(HPClNOL)Fe(μ-O)Fe(HPClNOL)Cl]Cl2·2H2O (2), and [(SO4)(HPClNOL)Fe(μ-O)Fe(HPClNOL)(SO4)]·6H2O (3) (HPClNOL=1-(bis-pyridin-2-ylmethyl-amino)-3-chloropropan-2-ol), were investigated. Each complex was able to promote plasmid DNA cleavage and change the supercoiled form of the plasmid to circular and linear ones. Kinetic data revealed that (1), (2) and (3) increase the rate of DNA hydrolysis about 278, 192 and 339 million-fold, respectively. The activity of the complexes was inhibited by distamycin, indicating that they interact with the minor groove of the DNA. The cytotoxic activity of the complexes toward U937, HL-60, Jukart and THP-1 leukemia cancer cells was studied employing 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT), fluorescence and electronic transmission microscopies, flow cytometry and a cytochrome C release assay. Compound (2) has the highest activity toward cancer cells and is the least toxic for normal ones (i.e. peripheral blood mononuclear cells (PBMCs)). In contrast, compound (1) is the least active toward cancer cells but displays the highest toxicity toward normal cells. Transmission electronic microscopy indicates that cell death shows features typical of apoptotic cells, which was confirmed using the annexin V-FITC/PI (fluorescein isothiocyanate/propidium iodide) assay. Furthermore, our data demonstrate that at an early stage during the treatment with complex (2) mitochondria lose their transmembrane potential, resulting in cytochrome C release. A quantification of caspases 3, 9 (intrinsic apoptosis pathway) and caspase 8 (extrinsic apoptosis pathway) indicated that both the intrinsic (via mitochondria) and extrinsic (via death receptors) pathways are involved in the apoptotic stimuli.
研究了铁配合物[Fe(HPClNOL)Cl2]NO3(1)、[Cl(HPClNOL)Fe(μ-O)Fe(HPClNOL)Cl]Cl2·2H2O(2)和[(SO4)(HPClNOL)Fe(μ-O)Fe(HPClNOL)(SO4)]·6H2O(3)(HPClNOL=1-(双吡啶-2-基甲基-氨基)-3-氯-2-丙醇)的核酸酶活性和对人白血病癌细胞的细胞毒性。每个配合物都能够促进质粒 DNA 切割,并将超螺旋质粒转变为环形和线性形式。动力学数据表明,(1)、(2)和(3)分别将 DNA 水解的速率提高了约 278、192 和 339 百万倍。配合物的活性被 Distamycin 抑制,表明它们与 DNA 的小沟相互作用。通过 3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴化物(MTT)、荧光和电子传输显微镜、流式细胞术和细胞色素 C 释放测定研究了配合物对 U937、HL-60、Jukart 和 THP-1 白血病癌细胞的细胞毒性。化合物(2)对癌细胞的活性最高,对正常细胞(即外周血单核细胞(PBMCs))的毒性最小。相比之下,化合物(1)对癌细胞的活性最低,但对正常细胞的毒性最高。透射电子显微镜表明细胞死亡呈现出典型的凋亡细胞特征,这通过 Annexin V-FITC/PI(荧光素异硫氰酸酯/碘化丙啶)测定得到了证实。此外,我们的数据表明,在使用配合物(2)治疗的早期阶段,线粒体失去跨膜电位,导致细胞色素 C 释放。半胱天冬酶 3、9(内在凋亡途径)和半胱天冬酶 8(外在凋亡途径)的定量分析表明,内在(通过线粒体)和外在(通过死亡受体)途径都参与了凋亡刺激。